Navigation Links
New Cardiovascular risk guidelines drafted

Professor David Woods with other scientists from British Cardiac Society, the British Hypertension Society, Diabetes UK, HEART UK, the Primary Care Cardiovascular Society // and the Stroke Association have collaboratively drafted guidelines for preventing cardiovascular risks of heart attacks, stroke and hardening of leg arteries. The new guidelines is drafted to reduce the risk of developing heart attacks by properly maintaining one’s lifestyle and early detection of risks associated with heart attacks so that early treatment could be started to prevent heart attacks. The new guidelines drafted by the Joint British society provide guidelines for increasing the screening and prevention of heart attacks.

People with high risk of cardiovascular disease are monitored with blood pressure, blood cholesterol and blood sugar and if their risk of developing cardiovascular disease is higher the risk of developing heart attacks are high. The patients are screened for cardiovascular disease following the below criteria (Source: Eurekalert):

Criteria or Group I: All adults aged 40 and older, with no history of heart attack, stroke, or diabetes, and not already being treated for high blood pressure or cholesterol.

Criteria or Group II: All adults under 40 with a family history of developing hardened and narrowed arteries earlier than expected.

Source: Eurekalert.


'"/>




Page: 1

Related medicine news :

1. High iron levels may cause Cardiovascular Disease in women
2. Air Pollution said To Increase Risk of Cardiovascular Disease
3. Link Between Alcohol Consumption And Cardiovascular Disease
4. Beer Found To Be Effective In Fighting Cardiovascular Disease
5. New Guidelines Found To Benefit Cardiovascular Treatment
6. Women With A High-Risk Of Cardiovascular Disease Under treated
7. Obesity and Physical inactivity is associated with Diabetes and Diabetes-Related Cardiovascular Comorbidities
8. Fitness levels in Men Correale with risk of Cardiovascular disease
9. Obesity Common Thread In Pregnancy Complications And Cardiovascular Woes
10. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
11. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: